Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.10.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.10.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.10.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.10.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.10.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.10.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.24EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.7.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.24ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.7.24ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.7.24EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.7.24EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.7.24ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.10ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.10EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20259.7China
BA.2.44EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.44ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.44ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.44EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.44EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.44ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.44ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BE.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BE.1.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BE.1.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BE.1.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BE.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.4.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.7.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.4.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BF.7.4.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BF.7.4.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BF.7.4.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BF.7.4.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.5.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.5.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.5.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.5.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used